Quantification of Macular Microvascular Changes in Retinitis Pigmentosa Using Optical Coherence Tomography Angiography.
OCT angiography
macular microvasculature
retinitis pigmentosa
Journal
Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512
Informations de publication
Date de publication:
2020
2020
Historique:
received:
31
03
2020
accepted:
02
06
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
2
7
2020
Statut:
epublish
Résumé
To investigate macular structural and microvascular changes in retinitis pigmentosa (RP) eyes compared to age-matched controls using spectral domain optical coherence tomography (SD-OCT) and OCT angiography (OCTA). This was a cross-sectional study. The foveal and parafoveal thickness and extent of ellipsoid zone (EZ) disruption were measured on OCT. The foveal avascular zone (FAZ) area and retinal vessel density (VD) were automatically calculated for superficial (SCP) and deep capillary plexuses (DCP) and choriocapillaris using OCTA-integrated software. VD was assessed for the whole 6 × 6 mm image, foveal and parafoveal regions. Quantitative measures were compared between healthy and diseased eyes. The study included 30 eyes of 30 RP patients and 24 eyes of 24 controls. Mean age was 26.9±6.4 years for RP patients and 27.4±4.9 years for controls (p=0.76). Mean LogMAR visual acuity (VA) was 0.9±0.5 for RP patients and 0.05±0.05 for controls (p <0.001). Foveal and parafoveal thicknesses were significantly lower in RP cases as compared to the control group. EZ disruption was observed in RP cases only (869±211 µm). Mean FAZ area was significantly larger in RP eyes in both SCP and DCP. VD was significantly reduced in RP eyes at the level of SCP, DCP and choriocapillaris. VA, deep parafoveal VD, foveal, parafoveal and whole image choriocapillaris VD were negatively correlated with the extent of EZ disruption. We report OCTA findings in a relatively young cohort of RP patients. We demonstrated a reduction of retinal microvascular density in all studied layers on OCTA. We believe studying retinal vasculature in these patients is important, as a healthy blood supply is a prerequisite for the success of new cell-based therapies under trial for RP.
Identifiants
pubmed: 32606586
doi: 10.2147/OPTH.S254909
pii: 254909
pmc: PMC7319527
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1705-1713Informations de copyright
© 2020 AttaAllah et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Br J Ophthalmol. 2017 Apr;101(4):428-432
pubmed: 27343210
EPMA J. 2012 Dec 03;3(1):17
pubmed: 23199279
Sci Rep. 2018 Sep 3;8(1):13130
pubmed: 30177829
Exp Eye Res. 2012 Aug;101:90-6
pubmed: 22721720
Acta Ophthalmol. 2018 Feb;96(1):e59-e67
pubmed: 28561452
Am J Ophthalmol. 1970 May;69(5):826-35
pubmed: 5441355
Retina. 2012 Sep;32(8):1581-91
pubmed: 22922847
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6360-6366
pubmed: 27898981
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
Front Neurol. 2017 Oct 27;8:572
pubmed: 29163338
Life Sci. 2014 Nov 24;118(2):386-90
pubmed: 24735956
Prog Retin Eye Res. 1998 Apr;17(2):175-205
pubmed: 9695792
Am J Ophthalmol. 1971 Jan;71(1 Pt 1):17-26
pubmed: 5541185
Curr Genomics. 2011 Jun;12(4):260-6
pubmed: 22131871
Sci Rep. 2017 Apr 13;7:46396
pubmed: 28406171
Sci Rep. 2016 Feb 25;6:22017
pubmed: 26912261
JAMA Ophthalmol. 2016 Jun 1;134(6):628-35
pubmed: 27031504
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1287-1295
pubmed: 28314954
JAMA Ophthalmol. 2013 Sep;131(9):1143-50
pubmed: 23828615
Acta Ophthalmol. 2014 Aug;92(5):454-60
pubmed: 24767408
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
Doc Ophthalmol. 2013 Jun;126(3):187-97
pubmed: 23408312
Br J Ophthalmol. 2013 Jan;97(1):66-9
pubmed: 23093617
Am J Ophthalmol. 2006 Dec;142(6):945-52
pubmed: 17157580
Int Ophthalmol. 2013 Jun;33(3):237-44
pubmed: 23160825
Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):1064-9
pubmed: 20861481
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):433-438
pubmed: 29365150
Acta Ophthalmol. 2015 Dec;93(8):e644-8
pubmed: 25688697
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):243-52
pubmed: 25952041
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Exp Eye Res. 2016 Sep;150:149-65
pubmed: 27020758
Retina. 2017 Oct 24;:
pubmed: 29068913
Ophthalmology. 1995 May;102(5):805-16
pubmed: 7777280
Am J Ophthalmol. 1996 Oct;122(4):502-8
pubmed: 8862046
Can J Physiol Pharmacol. 2010 Jun;88(6):630-5
pubmed: 20628428
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1807-1816
pubmed: 29982897